查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600594

中心實驗室市場：按服務類型、階段、治療領域和最終用途分類 - 全球預測 2025-2030

Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，中心實驗室市場價值為31.1億美元，預計到2024年將達到33.8億美元，複合年成長率為9.25%，到2030年將達到57.8億美元。

中心實驗室市場由實驗室網路組成，透過提供標準化化驗服務來支援臨床試驗，確保不同設施之間的測試一致且可靠。對於製藥公司、生物技術公司和委外研發機構(CRO) 來說，實驗室至關重要，因為它們提供加快藥物開發過程的基本服務，例如集中資料、標準化測試程序和縮短交付時間。隨著臨床試驗變得更加複雜和全球化，對中心實驗室的需求不斷成長，需要更嚴格地遵守監管標準並促進加強資料管理。主要應用是藥物代謝測試、生物標記分析和伴同性診斷，特別是在腫瘤學和慢性病臨床試驗。市場開拓的驅動力是開發新藥需求的增加、診斷檢測技術的進步以及個人化醫療範圍的擴大。存在機會擴展到新興市場並利用基因組學和蛋白​​質組學的進步來提供更專業的服務。然而，市場成長面臨嚴格的法律規範、高營運成本以及與各種臨床試驗設施的資料管理和整合相關的挑戰等形式的限制。競爭因素包括潛在的資料隱私風險以及不斷升級技術基礎設施以保持競爭力的需求。需要探索的創新領域包括引入人工智慧和機器學習來增強資料分析、流程自動化和預測分析。此外，開發用於無縫資料傳輸的整合平台並與高科技公司合作以確保資料的安全處理可以帶來可觀的回報。中央實驗室市場受到所面臨的挑戰、對創新治療解決方案的持續需求以及將最尖端科技融入實驗室服務的推動，相關人員不斷創新和成長，我們為它們提供了絕佳的機會。

主要市場統計
基準年[2023] 31.1億美元
預計年份 [2024] 33.8億美元
預測年份 [2030] 57.8億美元
複合年成長率（%） 9.25%

市場動態：揭示快速發展的中央實驗室市場的關鍵市場洞察

供需的動態交互作用正在改變中央實驗室市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 臨床試驗數量不斷增加，藥物開發活動的複雜性不斷增加
    • 政府在全球推廣精準醫療的舉措
  • 市場限制因素
    • 建立和維護中央研究實驗室的成本高昂
  • 市場機會
    • 中心實驗室技術整合及智慧化功能
    • 中央研究院設立及擴建投資
  • 市場挑戰
    • 操作限制和標準化複雜性

波特五力：駕馭中央實驗室市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解中央實驗室市場的外部影響

外部宏觀環境因素在塑造中央實驗室市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解中心實​​驗室市場的競爭狀況

中央實驗室市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣中央實驗室市場供應商的績效評估

FPNV定位矩陣是評估中心實驗室市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 臨床試驗數量不斷增加，藥物開發活動的複雜性不斷增加
      • 政府在全球推廣精準醫療的舉措
    • 抑制因素
      • 建立和維護中心實驗室的成本很高。
    • 機會
      • 中心實驗室的技術整合和智慧功能
      • 投資建立與擴大中心實驗室
    • 任務
      • 操作限制和標準化複雜性
  • 市場區隔分析
    • 服務類型：優先選擇中心實驗室在受控條件下長期保存生物樣本進行專門管理
    • 階段：中心實驗室在整個臨床試驗過程執行中的關鍵作用
    • 最終用途：必須促進無縫臨床試驗，同時確保製藥公司的資料完整性和卓越營運
    • 治療領域：腫瘤和感染疾病治療領域的綜合診斷和預後檢測
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 中心實驗室市場：依服務類型

  • 解剖病理學/組織學
  • 生物標誌服務
  • 遺傳服務
  • 微生物學服務
  • 特種化學品服務
  • 標本管理及儲存

第7章 中心實驗室市場分階段

  • 第一階段
  • 第二階段
  • 第三階段

第8章依治療領域分類的中心實驗室市場

  • 自體免疫疾病
  • 心血管疾病
  • 感染疾病
  • 神經病學
  • 腫瘤學

第 9 章 中心實驗室市場：依最終用途分類

  • 學術研究所
  • 生技公司
  • 病理學和診斷實驗室
  • 製藥公司

第10章美洲的中心實驗室市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太中心實驗室市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的中心實驗室市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Medpace 中央實驗室擴建新加坡工廠
    • Vial 宣布與 MLM Medical Labs 合作提供中央測試解決方案
    • Cerba Healthcare 收購加拿大合約研究組織 CIRION BioPharma Research，以擴大生物分析能力並減少進行複雜臨床試驗的時間
    • 克利夫蘭診所和 LabConnect 宣佈建立策略聯盟以改善患者照護
    • Versiti 收購總部位於印第安納州的 Quantigen，以加速臨床前研究服務的創新
    • Wispringhof 職業醫學大學與 Labconnect 宣布策略合作夥伴關係—擴大全球中心實驗室服務以加速藥物開發
    • IQVIA 和 (RED) 宣佈建立突破性夥伴關係，幫助增強實驗室系統
    • Cerba Investigations 為化驗服務合作夥伴提供客製化和創新的方法
    • Medpace 中心實驗室擴大組織學和解剖病理學服務
    • Thermo Fisher 投資 5,900 萬美元擴大美國臨床研究實驗室

公司名單

  • ACM Medical Laboratory, Inc.
  • Almac Group
  • Cerba HealthCare
  • CROMSOURCE by ClinChoice
  • Cryoport, Inc.
  • Eurofins Scientific SE
  • Exagen Inc.
  • Frontage Laboratories, Inc.
  • GBA Group
  • GCCL Co., Ltd.
  • ICON PLC
  • InterlabCorp
  • Intertek Group PLC
  • IQVIA Inc.
  • LabConnect, Inc.
  • Laboratory Corporation of America Holdings
  • Lambda Therapeutic Research Ltd.
  • Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
  • MDS Pharma Services
  • Medicover AB
  • Medpace, Inc.
  • MLM Medical Labs GmbH
  • Novotech Health Holdings
  • Pace Analytical Services, LLC
  • Precision Medicine Group, LLC
  • Quest Diagnostics Incorporated
  • REPROCELL Inc.
  • SGS SA
  • Shanghai Clinical Research Center
  • SMS Pharmaceuticals Ltd.
  • Sonic Healthcare International
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • Unilabs AB
  • Versiti, Inc.
  • WuXi AppTec
Product Code: MRR-F927BA462EBB

The Central Lab Market was valued at USD 3.11 billion in 2023, expected to reach USD 3.38 billion in 2024, and is projected to grow at a CAGR of 9.25%, to USD 5.78 billion by 2030.

The Central Lab market comprises a network of laboratories that support clinical trials by providing standardized laboratory services, ensuring consistent and reliable testing across different sites. These labs are crucial for pharmaceutical companies, biotech firms, and contract research organizations (CROs) as they offer centralization of data, uniformity in testing procedures, and reduction in turnaround times-vital for speeding up drug development processes. The necessity for central labs has grown with the increasing complexity and globalization of clinical trials, requiring strict adherence to regulatory standards and facilitating enhanced data management. Applications mainly encompass drug metabolism studies, biomarker analyses, and companion diagnostics, especially in oncology and chronic disease trials. The market's growth is driven by heightened demand for new drug development, technological advancements in diagnostic testing, and a broader scope for personalized medicine. Opportunities lie in the expansion into emerging markets and leveraging advancements in genomics and proteomics to offer more specialized services. However, market growth faces limitations in the form of stringent regulatory frameworks, high operational costs, and challenges associated with data management and integration across various trial sites. Adverse factors include potential risks related to data privacy and the need for constantly upgrading technological infrastructure to stay competitive. Innovative areas to explore include the incorporation of artificial intelligence and machine learning to enhance data analysis, process automation, and predictive analytics. Moreover, developing integrated platforms for seamless data transfer and partnering with tech companies to ensure secure data handling could offer significant returns. The Central Lab market, while facing challenges, presents robust opportunities for stakeholders to innovate and grow, largely driven by the continuous demand for innovative therapeutic solutions and the integration of cutting-edge technologies into laboratory services.

KEY MARKET STATISTICS
Base Year [2023] USD 3.11 billion
Estimated Year [2024] USD 3.38 billion
Forecast Year [2030] USD 5.78 billion
CAGR (%) 9.25%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Central Lab Market

The Central Lab Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the number of clinical trials and complexity of drug development activities
    • Government initiatives promoting precision medicine worldwide
  • Market Restraints
    • High cost of set-up and maintenance of central labs
  • Market Opportunities
    • Technological integrations and smart features in central labs
    • Investments for establishment and expansion of central labs
  • Market Challenges
    • Operational limitations and standardization complexities

Porter's Five Forces: A Strategic Tool for Navigating the Central Lab Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Central Lab Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Central Lab Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Central Lab Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Central Lab Market

A detailed market share analysis in the Central Lab Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Central Lab Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Central Lab Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Central Lab Market, highlighting leading vendors and their innovative profiles. These include ACM Medical Laboratory, Inc., Almac Group, Cerba HealthCare, CROMSOURCE by ClinChoice, Cryoport, Inc., Eurofins Scientific SE, Exagen Inc., Frontage Laboratories, Inc., GBA Group, GCCL Co., Ltd., ICON PLC, InterlabCorp, Intertek Group PLC, IQVIA Inc., LabConnect, Inc., Laboratory Corporation of America Holdings, Lambda Therapeutic Research Ltd., Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd., MDS Pharma Services, Medicover AB, Medpace, Inc., MLM Medical Labs GmbH, Novotech Health Holdings, Pace Analytical Services, LLC, Precision Medicine Group, LLC, Quest Diagnostics Incorporated, REPROCELL Inc., SGS S.A., Shanghai Clinical Research Center, SMS Pharmaceuticals Ltd., Sonic Healthcare International, Syngene International Limited, Thermo Fisher Scientific Inc., Unilabs AB, Versiti, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Central Lab Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service Type, market is studied across Anatomic Pathology/Histology, Biomarker Services, Genetic Services, Microbiology Services, Special Chemistry Services, and Specimen Management & Storage.
  • Based on Phase, market is studied across Phase 1, Phase 2, and Phase 3.
  • Based on Therapeutic Area, market is studied across Autoimmune Diseases, Cardiovascular Diseases, Infectious Diseases, Neurology, and Oncology.
  • Based on End-use, market is studied across Academic & Research Institutes, Biotechnology Companies, Pathology & Diagnostic Lab, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the number of clinical trials and complexity of drug development activities
      • 5.1.1.2. Government initiatives promoting precision medicine worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of set-up and maintenance of central labs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological integrations and smart features in central labs
      • 5.1.3.2. Investments for establishment and expansion of central labs
    • 5.1.4. Challenges
      • 5.1.4.1. Operational limitations and standardization complexities
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services Type: Preference for central labs for long-term storage of biological samples under controlled conditions for specific management
    • 5.2.2. Phase: Integral role of the central labs for the execution of the entire clinical trial process
    • 5.2.3. End-use: Need to facilitate seamless clinical trials, ensuring data integrity and operational excellence for pharmaceutical companies
    • 5.2.4. Therapeutic Area: Comprehensive diagnostic and prognostic testing for oncology and infectious diseases therapeutic areas
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Central Lab Market, by Service Type

  • 6.1. Introduction
  • 6.2. Anatomic Pathology/Histology
  • 6.3. Biomarker Services
  • 6.4. Genetic Services
  • 6.5. Microbiology Services
  • 6.6. Special Chemistry Services
  • 6.7. Specimen Management & Storage

7. Central Lab Market, by Phase

  • 7.1. Introduction
  • 7.2. Phase 1
  • 7.3. Phase 2
  • 7.4. Phase 3

8. Central Lab Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cardiovascular Diseases
  • 8.4. Infectious Diseases
  • 8.5. Neurology
  • 8.6. Oncology

9. Central Lab Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology Companies
  • 9.4. Pathology & Diagnostic Lab
  • 9.5. Pharmaceutical Companies

10. Americas Central Lab Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Central Lab Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Central Lab Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Medpace Central Labs Expand Singapore Facility
    • 13.3.2. Vial Announces Collaborative Alliance with MLM Medical Labs for offering Central Laboratory Solutions
    • 13.3.3. Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research to Expand Bioanalytical Capabilities and Shorten Time-to-Deploy Complex Clinical Trials
    • 13.3.4. Cleveland Clinic and LabConnect announce Strategic Alliance for Improved Patient Care
    • 13.3.5. Versiti Acquires Indiana-based Quantigen for Accelerating Pace of Innovation for Preclinical Research Services
    • 13.3.6. Labor Dr. Wisplinghoff and Labconnect Announce Strategic Alliance - Expanding Global Central Laboratory Services to Accelerate the Development of Medicines
    • 13.3.7. IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
    • 13.3.8. Cerba Research Offers a Customized, Innovative Approach to its Partners in the Laboratory Services
    • 13.3.9. Medpace Central Labs Expand Histology & Anatomic Pathology Services
    • 13.3.10. Thermo Fisher to invest USD 59 Million for Clinical Research Lab Expansion in the U.S.

Companies Mentioned

  • 1. ACM Medical Laboratory, Inc.
  • 2. Almac Group
  • 3. Cerba HealthCare
  • 4. CROMSOURCE by ClinChoice
  • 5. Cryoport, Inc.
  • 6. Eurofins Scientific SE
  • 7. Exagen Inc.
  • 8. Frontage Laboratories, Inc.
  • 9. GBA Group
  • 10. GCCL Co., Ltd.
  • 11. ICON PLC
  • 12. InterlabCorp
  • 13. Intertek Group PLC
  • 14. IQVIA Inc.
  • 15. LabConnect, Inc.
  • 16. Laboratory Corporation of America Holdings
  • 17. Lambda Therapeutic Research Ltd.
  • 18. Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
  • 19. MDS Pharma Services
  • 20. Medicover AB
  • 21. Medpace, Inc.
  • 22. MLM Medical Labs GmbH
  • 23. Novotech Health Holdings
  • 24. Pace Analytical Services, LLC
  • 25. Precision Medicine Group, LLC
  • 26. Quest Diagnostics Incorporated
  • 27. REPROCELL Inc.
  • 28. SGS S.A.
  • 29. Shanghai Clinical Research Center
  • 30. SMS Pharmaceuticals Ltd.
  • 31. Sonic Healthcare International
  • 32. Syngene International Limited
  • 33. Thermo Fisher Scientific Inc.
  • 34. Unilabs AB
  • 35. Versiti, Inc.
  • 36. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. CENTRAL LAB MARKET RESEARCH PROCESS
  • FIGURE 2. CENTRAL LAB MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CENTRAL LAB MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CENTRAL LAB MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CENTRAL LAB MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CENTRAL LAB MARKET DYNAMICS
  • TABLE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY ANATOMIC PATHOLOGY/HISTOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOMARKER SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY GENETIC SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY MICROBIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIAL CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIMEN MANAGEMENT & STORAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CENTRAL LAB MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CENTRAL LAB MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CENTRAL LAB MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CENTRAL LAB MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CENTRAL LAB MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CENTRAL LAB MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CENTRAL LAB MARKET SIZE, BY PATHOLOGY & DIAGNOSTIC LAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CENTRAL LAB MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 197. CENTRAL LAB MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. CENTRAL LAB MARKET, FPNV POSITIONING MATRIX, 2023